+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pneumonia Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • PDF Icon

    Report

  • 181 Pages
  • October 2025
  • Region: Global
  • Acute Market Reports
  • ID: 6182115
Description Jump to:
The global pneumonia therapeutics market is projected to grow at a CAGR of 8.6% from 2025 to 2033, driven by the increasing incidence of community- and hospital-acquired pneumonia, rising geriatric population, and advancements in antibiotic formulations and vaccines. Pneumonia continues to be a major cause of morbidity and mortality, especially among children under five and elderly populations. The rising prevalence of drug-resistant bacterial strains and greater awareness of early diagnosis and treatment are further boosting therapeutic demand.

Growing Incidence and Advancements in Treatment

The market is expanding as healthcare systems worldwide intensify efforts to combat respiratory infections through improved vaccination coverage, faster diagnostics, and next-generation antibiotics. Rising healthcare expenditure, particularly in developing nations, and increased access to advanced care facilities have fueled demand for both branded and generic pneumonia therapeutics. Biopharmaceutical companies are investing in novel drug formulations, combination therapies, and inhaled antibiotic delivery systems, while public health agencies continue to promote preventive immunization programs against pneumococcal infections.

Challenges: Antibiotic Resistance and Regulatory Complexity

The market faces significant challenges due to the emergence of multidrug-resistant (MDR) pathogens, limiting the effectiveness of traditional antibiotics. Moreover, the high cost and long timelines associated with the development and approval of new antibacterial drugs discourage innovation. However, the growing shift toward personalized medicine, novel mechanisms of action, and monoclonal antibody-based therapies is expected to create new growth opportunities over the forecast period.

Market Segmentation by Infection Type

In 2024, community-acquired pneumonia (CAP) accounted for the largest market share, driven by its widespread prevalence, especially in low- and middle-income countries. Improved access to outpatient care and rapid point-of-care diagnostics are supporting the growth of CAP treatment. The hospital-acquired pneumonia (HAP) segment is expected to record the highest CAGR due to the increasing number of hospitalized and immunocompromised patients, particularly those undergoing invasive procedures. Growing awareness of nosocomial infections and expanded antibiotic stewardship programs are also contributing to segmental growth.

Market Segmentation by Age Group

In 2024, the geriatrics segment dominated the market, as older adults are more susceptible to severe pneumonia due to weakened immune systems and coexisting health conditions such as COPD, diabetes, and heart disease. The pediatrics segment is projected to witness steady growth, supported by large patient pools in developing regions and expanding pediatric vaccination programs. The adult population remains a critical focus area for preventive vaccination and antibiotic therapy as lifestyle and pollution-related respiratory conditions rise globally.

Regional Insights

In 2024, North America held the largest market share, driven by robust healthcare infrastructure, availability of advanced antibiotics, and strong presence of leading pharmaceutical companies. Europe followed, supported by government-funded vaccination campaigns and antibiotic resistance monitoring programs. The Asia Pacific region is expected to record the highest CAGR, owing to high pneumonia prevalence rates, improving access to healthcare, and growing awareness of immunization and antibiotic therapy in countries such as India, China, and Indonesia. Latin America and Middle East & Africa (MEA) represent emerging markets where increasing healthcare investments and pneumonia awareness initiatives are gradually improving treatment accessibility.

Competitive Landscape

The pneumonia therapeutics market is moderately consolidated, with global players focusing on R&D for novel antibiotics, vaccine combinations, and respiratory biologics. Pfizer, GlaxoSmithKline, and AstraZeneca lead the market with strong antibiotic and vaccine portfolios addressing pneumococcal infections. F. Hoffmann-La Roche, Bayer, and Merck & Co. continue to invest in advanced formulations and combination therapies targeting resistant bacterial strains. Abbott Laboratories, AbbVie, and Bristol Myers Squibb are active in immunomodulatory and supportive treatment segments. Generic and regional manufacturers such as Cipla, Lupin Pharmaceuticals, Mylan, and Teva Pharmaceuticals play a key role in making pneumonia drugs affordable in developing markets. Novartis, Baxter International, Johnson & Johnson, and Daiichi Sankyo are investing in targeted therapies and vaccine development. Competitive strategies emphasize drug resistance management, product differentiation, and distribution network expansion, ensuring that innovation and accessibility remain central to pneumonia control efforts worldwide.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Pneumonia Therapeutics market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users & consumption volume, price, and value.
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Pneumonia Therapeutics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Infection Type
    • Community-acquired pneumonia (CAP)
    • Hospital-acquired pneumonia (HAP)
    • Ventilator-associated pneumonia (VAP)
    • Other infection types

  • Treatment Type
    • Drug class
      • Antibacterial drugs
      • Quinolones
      • Macrolide
      • Other antibacterial drugs
      • Antiviral drugs
      • Antifungal drugs
      • Other drug classes

    • Vaccines
    • Oxygen therapy

  • Age Group
    • Pediatrics
    • Adults
    • Geriatrics

  • Route of Administration
    • Oral
    • Parenteral
    • Other routes of administration

  • End Use
    • Hospitals and clinics
    • Homecare settings
    • Other end use

Regional Segmentation (2023-2033; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Pneumonia Therapeutics market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Pneumonia Therapeutics market?
  • Which is the largest regional market for Pneumonia Therapeutics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Pneumonia Therapeutics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Pneumonia Therapeutics market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Pneumonia Therapeutics Market
2.2. Global Pneumonia Therapeutics Market, by Infection Type, 2024 (US$ Million)
2.3. Global Pneumonia Therapeutics Market, by Treatment Type, 2024 (US$ Million)
2.4. Global Pneumonia Therapeutics Market, by Age Group, 2024 (US$ Million)
2.5. Global Pneumonia Therapeutics Market, by Route of Administration, 2024 (US$ Million)
2.6. Global Pneumonia Therapeutics Market, by End Use, 2024 (US$ Million)
2.7. Global Pneumonia Therapeutics Market, by Geography, 2024 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2024
3. Pneumonia Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Pneumonia Therapeutics Market Vendors
3.2. Strategies Adopted by Pneumonia Therapeutics Market Vendors
4. Pneumonia Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Pneumonia Therapeutics Market Value, 2023-2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Community-acquired pneumonia (CAP)
5.3.2. Hospital-acquired pneumonia (HAP)
5.3.3. Ventilator-associated pneumonia (VAP)
5.3.4. Other infection types
6. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Drug class
6.3.1.1. Antibacterial drugs
6.3.1.2. Quinolones
6.3.1.3. Macrolide
6.3.1.4. Other antibacterial drugs
6.3.1.5. Antiviral drugs
6.3.1.6. Antifungal drugs
6.3.1.7. Other drug classes
6.3.2. Vaccines
6.3.3. Oxygen therapy
7. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Pediatrics
7.3.2. Adults
7.3.3. Geriatrics
8. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 Versus 2033
8.3. Market Segmentation
8.3.1. Oral
8.3.2. Parenteral
8.3.3. Other routes of administration
9. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2024 Versus 2033
9.3. Market Segmentation
9.3.1. Hospitals and clinics
9.3.2. Homecare settings
9.3.3. Other end use
10. North America Pneumonia Therapeutics Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
10.3. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
10.4. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
10.5. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.6. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
10.7. Pneumonia Therapeutics Market: by Region, 2023-2033, USD (Million)
10.7.1. North America
10.7.1.1. U.S.
10.7.1.1.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
10.7.1.1.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
10.7.1.1.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
10.7.1.1.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.1.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
10.7.1.2.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
10.7.1.2.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
10.7.1.2.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.2.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
10.7.1.3.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
10.7.1.3.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
10.7.1.3.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
10.7.1.3.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11. UK and European Union Pneumonia Therapeutics Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.3. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.4. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.5. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.6. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7. Pneumonia Therapeutics Market: by Region, 2023-2033, USD (Million)
11.7.1. UK and European Union
11.7.1.1. UK
11.7.1.1.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.1.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.1.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.1.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.1.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.2.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.2.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.2.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.2.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.3.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.3.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.3.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.3.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.4.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.4.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.4.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.4.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7.1.5. France
11.7.1.5.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.5.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.5.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.5.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.5.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
11.7.1.6.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
11.7.1.6.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
11.7.1.6.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
11.7.1.6.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12. Asia Pacific Pneumonia Therapeutics Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.3. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.4. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.5. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.6. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7. Pneumonia Therapeutics Market: by Region, 2023-2033, USD (Million)
12.7.1. Asia Pacific
12.7.1.1. China
12.7.1.1.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.1.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.1.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.1.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.1.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.2.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.2.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.2.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.2.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7.1.3. India
12.7.1.3.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.3.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.3.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.3.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.3.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.4.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.4.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.4.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.4.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.5.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.5.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.5.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.5.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
12.7.1.6.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
12.7.1.6.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
12.7.1.6.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
12.7.1.6.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
13. Latin America Pneumonia Therapeutics Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
13.3. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
13.4. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
13.5. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.6. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
13.7. Pneumonia Therapeutics Market: by Region, 2023-2033, USD (Million)
13.7.1. Latin America
13.7.1.1. Brazil
13.7.1.1.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
13.7.1.1.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
13.7.1.1.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
13.7.1.1.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.1.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
13.7.1.2.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
13.7.1.2.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
13.7.1.2.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.2.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
13.7.1.3.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
13.7.1.3.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
13.7.1.3.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
13.7.1.3.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
14. Middle East and Africa Pneumonia Therapeutics Market, 2023-2033, USD (Million)
14.1. Market Overview
14.2. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
14.3. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
14.4. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
14.5. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.6. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
14.7. Pneumonia Therapeutics Market: by Region, 2023-2033, USD (Million)
14.7.1. Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
14.7.1.1.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
14.7.1.1.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
14.7.1.1.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.1.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
14.7.1.2.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
14.7.1.2.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
14.7.1.2.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.2.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Pneumonia Therapeutics Market: by Infection Type, 2023-2033, USD (Million)
14.7.1.3.2. Pneumonia Therapeutics Market: by Treatment Type, 2023-2033, USD (Million)
14.7.1.3.3. Pneumonia Therapeutics Market: by Age Group, 2023-2033, USD (Million)
14.7.1.3.4. Pneumonia Therapeutics Market: by Route of Administration, 2023-2033, USD (Million)
14.7.1.3.5. Pneumonia Therapeutics Market: by End Use, 2023-2033, USD (Million)
15. Company Profiles
15.1. Abbott Laboratories
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. AbbVie
15.3. AstraZeneca
15.4. Baxter International
15.5. Bayer
15.6. Bristol Myers Squibb
15.7. Cipla
15.8. Daiichi Sankyo
15.9. F. Hoffmann-La Roche
15.10. GlaxoSmithKline
15.11. Johnson & Johnson
15.12. Lupin Pharmaceuticals
15.13. Merck & Co.
15.14. Mylan
15.15. Novartis
15.16. Pfizer
15.17. Teva Pharmaceuticals
15.18. Other Notable Players
List of Figures
Figure 1 Global Pneumonia Therapeutics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Pneumonia Therapeutics Market: Quality Assurance
Figure 5 Global Pneumonia Therapeutics Market, by Infection Type, 2024
Figure 6 Global Pneumonia Therapeutics Market, by Treatment Type, 2024
Figure 7 Global Pneumonia Therapeutics Market, by Age Group, 2024
Figure 8 Global Pneumonia Therapeutics Market, by Route of Administration, 2024
Figure 9 Global Pneumonia Therapeutics Market, by End Use, 2024
Figure 10 Global Pneumonia Therapeutics Market, by Geography, 2024
Figure 11 Market Geographical Opportunity Matrix - Global Pneumonia Therapeutics Market, 2024
Figure 12 Market Positioning of Key Pneumonia Therapeutics Market Players, 2024
Figure 13 Global Pneumonia Therapeutics Market, by Infection Type, 2024 Vs 2033, %
Figure 14 Global Pneumonia Therapeutics Market, by Treatment Type, 2024 Vs 2033, %
Figure 15 Global Pneumonia Therapeutics Market, by Age Group, 2024 Vs 2033, %
Figure 16 Global Pneumonia Therapeutics Market, by Route of Administration, 2024 Vs 2033, %
Figure 17 Global Pneumonia Therapeutics Market, by End Use, 2024 Vs 2033, %
Figure 18 U.S. Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 19 Canada Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 20 Rest of North America Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 21 UK Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 22 Germany Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 23 Spain Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 24 Italy Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 25 France Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 26 Rest of Europe Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 27 China Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 28 Japan Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 29 India Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 30 Australia Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 31 South Korea Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 32 Rest of Asia Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 33 Brazil Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 34 Mexico Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 35 Rest of Latin America Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 36 GCC Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 37 Africa Pneumonia Therapeutics Market (US$ Million), 2023-2033
Figure 38 Rest of Middle East and Africa Pneumonia Therapeutics Market (US$ Million), 2023-2033
List of Tables
Table 1 Global Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 2 Global Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 3 Global Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 4 Global Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 5 Global Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 6 North America Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 7 North America Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 8 North America Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 9 North America Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 10 North America Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 11 U.S. Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 12 U.S. Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 13 U.S. Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 14 U.S. Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 15 U.S. Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 16 Canada Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 17 Canada Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 18 Canada Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 19 Canada Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 20 Canada Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 21 Rest of North America Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 22 Rest of North America Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 23 Rest of North America Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 24 Rest of North America Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 25 Rest of North America Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 26 UK and European Union Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 27 UK and European Union Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 28 UK and European Union Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 29 UK and European Union Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 30 UK and European Union Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 31 UK Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 32 UK Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 33 UK Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 34 UK Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 35 UK Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 36 Germany Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 37 Germany Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 38 Germany Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 39 Germany Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 40 Germany Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 41 Spain Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 42 Spain Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 43 Spain Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 44 Spain Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 45 Spain Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 46 Italy Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 47 Italy Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 48 Italy Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 49 Italy Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 50 Italy Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 51 France Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 52 France Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 53 France Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 54 France Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 55 France Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 56 Rest of Europe Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 57 Rest of Europe Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 58 Rest of Europe Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 59 Rest of Europe Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 60 Rest of Europe Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 61 Asia Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 62 Asia Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 63 Asia Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 64 Asia Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 65 Asia Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 66 China Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 67 China Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 68 China Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 69 China Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 70 China Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 71 Japan Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 72 Japan Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 73 Japan Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 74 Japan Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 75 Japan Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 76 India Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 77 India Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 78 India Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 79 India Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 80 India Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 81 Australia Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 82 Australia Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 83 Australia Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 84 Australia Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 85 Australia Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 86 South Korea Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 87 South Korea Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 88 South Korea Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 89 South Korea Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 90 South Korea Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 91 Latin America Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 92 Latin America Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 93 Latin America Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 94 Latin America Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 95 Latin America Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 96 Brazil Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 97 Brazil Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 98 Brazil Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 99 Brazil Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 100 Brazil Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 101 Mexico Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 102 Mexico Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 103 Mexico Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 104 Mexico Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 105 Mexico Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 106 Rest of Latin America Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 107 Rest of Latin America Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 108 Rest of Latin America Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 109 Rest of Latin America Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 110 Rest of Latin America Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 111 Middle East and Africa Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 112 Middle East and Africa Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 113 Middle East and Africa Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 114 Middle East and Africa Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 115 Middle East and Africa Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 116 GCC Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 117 GCC Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 118 GCC Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 119 GCC Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 120 GCC Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 121 Africa Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 122 Africa Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 123 Africa Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 124 Africa Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 125 Africa Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)
Table 126 Rest of Middle East and Africa Pneumonia Therapeutics Market by Infection Type, 2023-2033, USD (Million)
Table 127 Rest of Middle East and Africa Pneumonia Therapeutics Market by Treatment Type, 2023-2033, USD (Million)
Table 128 Rest of Middle East and Africa Pneumonia Therapeutics Market by Age Group, 2023-2033, USD (Million)
Table 129 Rest of Middle East and Africa Pneumonia Therapeutics Market by Route of Administration, 2023-2033, USD (Million)
Table 130 Rest of Middle East and Africa Pneumonia Therapeutics Market by End Use, 2023-2033, USD (Million)

Companies Mentioned

  • Abbott Laboratories
  • AbbVie
  • AstraZeneca
  • Baxter International
  • Bayer
  • Bristol Myers Squibb
  • Cipla
  • Daiichi Sankyo
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Johnson & Johnson
  • Lupin Pharmaceuticals
  • Merck & Co.
  • Mylan
  • Novartis
  • Pfizer
  • Teva Pharmaceuticals

Related Topics

Related Reports

Pneumonia Therapeutics Global Market Report 2025 - Product Image

Pneumonia Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Pneumonia Therapeutics - Global Strategic Business Report - Product Image

Pneumonia Therapeutics - Global Strategic Business Report

  • Report
  • 100 Pages
  • Global
From
Pneumonia Therapeutics Market - Global Forecast 2025-2032 - Product Image

Pneumonia Therapeutics Market - Global Forecast 2025-2032

  • Report
  • 185 Pages
  • Global
From
Pneumonia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pneumonia Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 138 Pages
  • Global
From
2025 Global Forecast for Pneumonia Therapeutics Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Pneumonia Therapeutics Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.